In a seminal study, Morató et al. (2021) demonstrated that Ecto-GPR37 levels are significantly elevated in the CSF of PD patients compared to healthy controls and patients with multiple system atrophy (MSA). The gene discussed is GPR37; the disease is Parkinson disease.